A detailed history of Squarepoint Ops LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 28,562 shares of TVTX stock, worth $496,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,562
Previous 15,580 83.32%
Holding current value
$496,693
Previous $128,000 211.72%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.89 - $15.21 $102,427 - $197,456
12,982 Added 83.32%
28,562 $399,000
Q2 2024

Aug 14, 2024

SELL
$5.26 - $8.28 $44,662 - $70,305
-8,491 Reduced 35.27%
15,580 $128,000
Q1 2024

May 15, 2024

SELL
$7.18 - $9.82 $730,263 - $998,772
-101,708 Reduced 80.86%
24,071 $185,000
Q4 2023

Feb 14, 2024

SELL
$5.44 - $9.5 $187,783 - $327,930
-34,519 Reduced 21.53%
125,779 $1.13 Million
Q2 2023

Aug 14, 2023

BUY
$15.3 - $22.61 $22,613 - $33,417
1,478 Added 0.93%
160,298 $2.46 Million
Q1 2023

May 15, 2023

BUY
$17.82 - $22.89 $2.58 Million - $3.31 Million
144,584 Added 1015.62%
158,820 $3.57 Million
Q4 2022

Feb 14, 2023

SELL
$18.47 - $26.14 $563,094 - $796,930
-30,487 Reduced 68.17%
14,236 $299,000
Q3 2022

Nov 14, 2022

BUY
$22.91 - $28.63 $695,547 - $869,206
30,360 Added 211.38%
44,723 $1.1 Million
Q2 2022

Aug 15, 2022

BUY
$20.94 - $30.01 $300,761 - $431,033
14,363 New
14,363 $348,000
Q4 2021

Feb 14, 2022

SELL
$24.34 - $31.17 $318,099 - $407,360
-13,069 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$12.98 - $25.03 $584,891 - $1.13 Million
-45,061 Reduced 77.52%
13,069 $317,000
Q2 2021

Aug 16, 2021

BUY
$14.11 - $26.4 $389,732 - $729,194
27,621 Added 90.53%
58,130 $848,000
Q1 2021

May 17, 2021

BUY
$23.37 - $31.77 $315,401 - $428,767
13,496 Added 79.33%
30,509 $762,000
Q4 2020

Feb 16, 2021

BUY
$19.17 - $27.87 $326,139 - $474,152
17,013 New
17,013 $464,000

Others Institutions Holding TVTX

About Travere Therapeutics, Inc.


  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.12B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.